Emcure Pharmaceuticals Ltd (EMCURE) — Cash Flow Reinvestment Rate
Emcure Pharmaceuticals Ltd (EMCURE) has a Cash Flow Reinvestment Rate of 0.50x as of September 2025, reinvesting Rs1.29 Billion (capex Rs1.29 Billion ) from operating cash flow of Rs2.56 Billion. Check EMCURE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Emcure Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2022–2026)
Historical reinvestment intensity for Emcure Pharmaceuticals Ltd across 5 annual periods. Explore Emcure Pharmaceuticals Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year capital reinvestment analysis for Emcure Pharmaceuticals Ltd. For live market cap and broader valuation context, see Emcure Pharmaceuticals Ltd (EMCURE) total market value.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.42x | Rs3.61 Billion | Rs8.51 Billion | Rs3.61 Billion | ▼ -27.9% |
| 2025 | 0.59x | Rs5.01 Billion | Rs8.52 Billion | Rs4.07 Billion | ▲ +54.8% |
| 2024 | 0.38x | Rs4.17 Billion | Rs10.97 Billion | Rs3.07 Billion | ▼ -40.2% |
| 2023 | 0.63x | Rs4.74 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -3.0% |
| 2022 | 0.65x | Rs5.03 Billion | Rs7.68 Billion | Rs3.97 Billion | — |